Abstract
Since most of the pathogenic microbes have developed resistance against chemical drug derivatives therefore need of the hour is to formulate plant based natural medicines. These formulations with no or least toxicity can prove better alternative of synthetic drugs. Ethnopharmacologists, botanists, microbiologists, and natural-products chemists are combing the earth for phytochemicals and “leads” which could be developed for the treatment of infectious diseases. While, 25 to 50% of current pharmaceuticals are derived from plants, none are used as antimicrobials. Traditional healers have long used plants to prevent or cure infectious conditions; western medicine is trying to duplicate their successes. Plants are rich in a wide variety of secondary metabolites, such as tannins, terpenoids, alkaloids, and flavonoids, which have been found in vitro to have antimicrobial properties. The present review mainly discusses exploitation of plant secondary compounds as antimicrobial agents. Mode of action of some agents was also addressed. Since many of these compounds are currently available as unregulated botanical preparations and their use by the public is increasing rapidly, clinicians need to consider the consequences of patients self-medicating with these preparations.
Keywords: Natural Drugs, Secondary metabolites, Antimicrobial agents, Botanical preparations, Pharmaceuticals, Plant, Natural product, Phytochemicals, Microbiologists, Synthetic drugs
The Natural Products Journal
Title: Antimicrobial Potential of Botanicals and Disease Control
Volume: 1 Issue: 2
Author(s): Madhu Rathore, Kanika Sharma and Naveen Sharma
Affiliation:
Keywords: Natural Drugs, Secondary metabolites, Antimicrobial agents, Botanical preparations, Pharmaceuticals, Plant, Natural product, Phytochemicals, Microbiologists, Synthetic drugs
Abstract: Since most of the pathogenic microbes have developed resistance against chemical drug derivatives therefore need of the hour is to formulate plant based natural medicines. These formulations with no or least toxicity can prove better alternative of synthetic drugs. Ethnopharmacologists, botanists, microbiologists, and natural-products chemists are combing the earth for phytochemicals and “leads” which could be developed for the treatment of infectious diseases. While, 25 to 50% of current pharmaceuticals are derived from plants, none are used as antimicrobials. Traditional healers have long used plants to prevent or cure infectious conditions; western medicine is trying to duplicate their successes. Plants are rich in a wide variety of secondary metabolites, such as tannins, terpenoids, alkaloids, and flavonoids, which have been found in vitro to have antimicrobial properties. The present review mainly discusses exploitation of plant secondary compounds as antimicrobial agents. Mode of action of some agents was also addressed. Since many of these compounds are currently available as unregulated botanical preparations and their use by the public is increasing rapidly, clinicians need to consider the consequences of patients self-medicating with these preparations.
Export Options
About this article
Cite this article as:
Rathore Madhu, Sharma Kanika and Sharma Naveen, Antimicrobial Potential of Botanicals and Disease Control, The Natural Products Journal 2011; 1 (2) . https://dx.doi.org/10.2174/2210315511101020105
DOI https://dx.doi.org/10.2174/2210315511101020105 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Carbohydrate Antigens: Synthesis Aspects and Immunological Applications in Cancer
Mini-Reviews in Medicinal Chemistry Regular Physical Activity and Vascular Aging
Current Pharmaceutical Design Non Steroidal Anti-Inflammatory Drug Induced Damage on Lower Gastro-Intestinal Tract: Is There an Involvement of Microbiota?
Current Drug Safety The Metabolic Rationale for a Lack of Cross-reactivity Between Sulfonamide Antimicrobials and Other Sulfonamide-containing Drugs
Drug Metabolism Letters Variation in the Level of Thyroid Markers in Association with Inflammation in Patients with Type 2 Diabetes
Endocrine, Metabolic & Immune Disorders - Drug Targets Recent Advances in Colon Drug Delivery Technology
Drug Delivery Letters Laminin and Collagen IV: Two Polypeptides as Marker of Dystocic Labor
Current Protein & Peptide Science Feline Immunodeficiency Virus Model for Designing HIV/AIDS Vaccines
Current HIV Research Simultaneous Determination of Cytochrome P450 Oxidation Capacity in Humans: A Review on the Phenotyping Cocktail Approach
Current Pharmaceutical Biotechnology IL-2, IL-7 and IL-15 as Immuno-Modulators During SIV/HIV Vaccination and Treatment
Current HIV Research Transgenic Plants Expressing Bacterial Genes as a Model System for Plant Functional Genomics
Current Genomics Evaluation of the <i>In Vivo</i> Acute Toxicity and <i>In Vitro</i> Hemolytic and Immunomodulatory Activities of the <i>Moringa oleifera</i> Flower Trypsin Inhibitor (MoFTI)
Protein & Peptide Letters Immune System Induction of Nerve Growth Factor in an Animal Model of Multiple Sclerosis: Implications in Re-Myelination and Myelin RepairATION AND MYELIN REPAIR
CNS & Neurological Disorders - Drug Targets MicroRNA Expression in Coronary Artery Disease
MicroRNA The Mouse In Cancer Research Past, Present, Future
Current Genomics Platelet-Monocyte Interactions - A Dangerous Liaison Linking Thrombosis, Inflammation and Atherosclerosis
Current Medicinal Chemistry Interferon-γ , Pulmonary Macrophages and Airway Responsiveness in Asthma
Inflammation & Allergy - Drug Targets (Discontinued) Natural Animal Models of Neurodegenerative Protein Misfolding Diseases
Current Pharmaceutical Design Recent Developments in Polymeric Nanoparticle Engineering and Their Applications in Experimental and Clinical Oncology
Anti-Cancer Agents in Medicinal Chemistry Breast Cancer: Current Developments in Molecular Approaches to Diagnosis and Treatment
Recent Patents on Anti-Cancer Drug Discovery